Single-cell Technology Firm Sphere Fluidics Raises $2.5M | GenomeWeb

NEW YORK (GenomeWeb News) – Single-cell technology firm Sphere Fluidics today announced the completion of a $2.5 million investment round.

24Haymarket led the round. Other investors included the Royal Society Enterprise Fund, Cambridge Enterprise, Providence Investment, the University of Cambridge Enterprise Fund, the London Business Angels Roundtable EIS Fund, and individual investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.